These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

119 related items for PubMed ID: 12621628

  • 1. Effects of dopaminergic cell degeneration on electrophysiological characteristics and GAD65/GAD67 expression in the substantia nigra: different action on GABA cell subpopulations.
    Díaz MR, Barroso-Chinea P, Acevedo A, González-Hernández T.
    Mov Disord; 2003 Mar; 18(3):254-266. PubMed ID: 12621628
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Response of the GABAergic and dopaminergic mesostriatal projections to the lesion of the contralateral dopaminergic mesostriatal pathway in the rat.
    González-Hernández T, Barroso-Chinea P, Rodríguez M.
    Mov Disord; 2004 Sep; 19(9):1029-1042. PubMed ID: 15372592
    [Abstract] [Full Text] [Related]

  • 4. Time-course of SKF-81297-induced increase in glutamic acid decarboxylase 65 and 67 mRNA levels in striatonigral neurons and decrease in GABA(A) receptor alpha1 subunit mRNA levels in the substantia nigra, pars reticulata, in adult rats with a unilateral 6-hydroxydopamine lesion.
    Yamamoto N, Soghomonian JJ.
    Neuroscience; 2008 Jun 26; 154(3):1088-99. PubMed ID: 18495353
    [Abstract] [Full Text] [Related]

  • 5. Distribution of GABAergic neurons in the striatum of amygdala-kindled rats: an immunohistochemical and in situ hybridization study.
    Löscher W, Schirmer M, Freichel C, Gernert M.
    Brain Res; 2006 Apr 14; 1083(1):50-60. PubMed ID: 16545783
    [Abstract] [Full Text] [Related]

  • 6. Electrophysiological and immunocytochemical characterization of GABA and dopamine neurons in the substantia nigra of the rat.
    Richards CD, Shiroyama T, Kitai ST.
    Neuroscience; 1997 Sep 14; 80(2):545-57. PubMed ID: 9284356
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Effects of nigrostriatal denervation and L-dopa therapy on the GABAergic neurons in the striatum in MPTP-treated monkeys and Parkinson's disease: an in situ hybridization study of GAD67 mRNA.
    Levy R, Herrero MT, Ruberg M, Villares J, Faucheux B, Guridi J, Guillen J, Luquin MR, Javoy-Agid F, Obeso JA.
    Eur J Neurosci; 1995 Jun 01; 7(6):1199-209. PubMed ID: 7582093
    [Abstract] [Full Text] [Related]

  • 11. Compartmental organization and chemical profile of dopaminergic and GABAergic neurons in the substantia nigra of the rat.
    González-Hernández T, Rodríguez M.
    J Comp Neurol; 2000 May 22; 421(1):107-35. PubMed ID: 10813775
    [Abstract] [Full Text] [Related]

  • 12. Colocalization of tyrosine hydroxylase and GAD65 mRNA in mesostriatal neurons.
    González-Hernández T, Barroso-Chinea P, Acevedo A, Salido E, Rodríguez M.
    Eur J Neurosci; 2001 Jan 22; 13(1):57-67. PubMed ID: 11135004
    [Abstract] [Full Text] [Related]

  • 13. The deep mesencephalic nucleus as an output center of basal ganglia: morphological and electrophysiological similarities with the substantia nigra.
    Rodríguez M, Abdala P, Barroso-Chinea P, González-Hernández T.
    J Comp Neurol; 2001 Sep 10; 438(1):12-31. PubMed ID: 11503150
    [Abstract] [Full Text] [Related]

  • 14. GFRalpha-1 mRNA in dopaminergic and nondopaminergic neurons in the substantia nigra and ventral tegmental area.
    Sarabi A, Hoffer BJ, Olson L, Morales M.
    J Comp Neurol; 2001 Dec 10; 441(2):106-17. PubMed ID: 11745638
    [Abstract] [Full Text] [Related]

  • 15. Messenger RNAs encoding glutamate-decarboxylases are differentially affected by nigrostriatal lesions in subpopulations of striatal neurons.
    Soghomonian JJ, Gonzales C, Chesselet MF.
    Brain Res; 1992 Mar 27; 576(1):68-79. PubMed ID: 1515913
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Subthalamic GAD gene therapy in a Parkinson's disease rat model.
    Luo J, Kaplitt MG, Fitzsimons HL, Zuzga DS, Liu Y, Oshinsky ML, During MJ.
    Science; 2002 Oct 11; 298(5592):425-9. PubMed ID: 12376704
    [Abstract] [Full Text] [Related]

  • 18. Effects of rimonabant, a selective cannabinoid CB1 receptor antagonist, in a rat model of Parkinson's disease.
    González S, Scorticati C, García-Arencibia M, de Miguel R, Ramos JA, Fernández-Ruiz J.
    Brain Res; 2006 Feb 16; 1073-1074():209-19. PubMed ID: 16412990
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Effects of nigrostriatal lesions on the levels of messenger RNAs encoding two isoforms of glutamate decarboxylase in the globus pallidus and entopeduncular nucleus of the rat.
    Soghomonian JJ, Chesselet MF.
    Synapse; 1992 Jun 16; 11(2):124-33. PubMed ID: 1626311
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.